Home Cart Sign in  
Chemical Structure| 6846-50-0 Chemical Structure| 6846-50-0

Structure of 6846-50-0

Chemical Structure| 6846-50-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Shalihi, Devy Janisca ; Murniati, Neni ; Rahman, Wiguna ; Hutabarat, Prima Wahyu Kusuma ; Lailaty, Intani Quarta ;

Abstract: Rhododendron multicolor Miq. exhibits distinctive morphoanatomical characteristics and various bioactive compounds with medicinal and horticultural potential. Numerous studies indicated Rhododendron species are widely utilized as medicinal and ornamental plants, owing to their diverse phytochemical profiles and distinctive morphoanatomical characteristics. However, comprehensive studies of the morphoanatomy and leaves metabolite profile of R. multicolor are still limited globally, as well as its minimal utilization by local communities, highlighting a significant knowledge gap. Therefore, this study aimed to analyze the morphology, paradermal anatomy, and metabolite profile of young leaves and mature leaves of R. multicolor. Morphoanatomy characteristics were analyzed descriptively, anatomical features were analyzed using specific formulas, and metabolite profiling was analyzed using qualitative phytochemicals and gas chromatography-mass spectrometry (GC-MS). The result shows that R. multicolor is a shrubby plant characterized by funnel-shaped flowers in a vibrant red hue, along with narrowly elliptic, scaly leaves. The scales are stellate lobed irregularly with lower density than stomata; the epidermis is polygonal to irregular that has a higher density compared to stomata. The results of the qualitative phytochemical test of Rhododendron multicolor are that it contains phenols, flavonoids, Mayer alkaloids, Bouchardat alkaloids, Dragendorf alkaloids, tannins, and saponins. Based on GC-MS analysis of young leaves and mature leaves of R. multicolor, a total of 31 metabolite compounds from 21 compound groups were identified, with the major compound being squalene from the terpenoid group, which has the potential to be an antioxidant, anticancer, antibacterial, antifungal, antitumor, and cardioprotective.

Keywords: Morphoanatomy ; metabolite compounds ; Rhododendron multicolor Miq ; Vireya ; Cibodas Botanic Garden

Purchased from AmBeed: ;

Alternative Products

Product Details of [ 6846-50-0 ]

CAS No. :6846-50-0
Formula : C16H30O4
M.W : 286.41
SMILES Code : CC(C)C(OC(C(C)C)=O)C(C)(C)COC(C(C)C)=O
MDL No. :MFCD00059267
InChI Key :OMVSWZDEEGIJJI-UHFFFAOYSA-N
Pubchem ID :23284

Safety of [ 6846-50-0 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 6846-50-0 ] Show Less

Physicochemical Properties

Num. heavy atoms 20
Num. arom. heavy atoms 0
Fraction Csp3 0.88
Num. rotatable bonds 9
Num. H-bond acceptors 4.0
Num. H-bond donors 0.0
Molar Refractivity 81.34
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

52.6 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

3.57
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

4.68
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

3.44
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

3.17
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

3.58
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

3.69

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-3.97
Solubility 0.0307 mg/ml ; 0.000107 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-5.51
Solubility 0.000881 mg/ml ; 0.00000307 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Moderately soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-3.0
Solubility 0.287 mg/ml ; 0.001 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

Yes
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-4.72 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

0.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

1.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<2.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

3.07
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 6846-50-0 ]

Aliphatic Chain Hydrocarbons

Chemical Structure| 25265-77-4

A774769 [25265-77-4]

2,2,4-Trimethyl-1,3-pentanediol 1-monoisobutyrate

Similarity: 1.00

Chemical Structure| 112245-04-2

A304423 [112245-04-2]

(R)-2-(2-(tert-Butoxy)-2-oxoethyl)-4-methylpentanoic acid

Similarity: 0.85

Chemical Structure| 210048-05-8

A659645 [210048-05-8]

(R)-4-(tert-Butoxy)-2-ethyl-4-oxobutanoic acid

Similarity: 0.85

Chemical Structure| 596-75-8

A141287 [596-75-8]

Diethyl 2,2-dibutylmalonate

Similarity: 0.82

Chemical Structure| 77-25-8

A674608 [77-25-8]

Diethyl Diethylmalonate

Similarity: 0.82

Esters

Chemical Structure| 25265-77-4

A774769 [25265-77-4]

2,2,4-Trimethyl-1,3-pentanediol 1-monoisobutyrate

Similarity: 1.00

Chemical Structure| 15840-96-7

A178337 [15840-96-7]

Cyclohexyl cyclohexanecarboxylate

Similarity: 0.88

Chemical Structure| 99974-66-0

A329292 [99974-66-0]

Diethyl 3-hydroxycyclobutane-1,1-dicarboxylate

Similarity: 0.86

Chemical Structure| 6125-55-9

A158706 [6125-55-9]

trans-Ethyl 2-hydroxycyclohexanecarboxylate

Similarity: 0.85

Chemical Structure| 6149-52-6

A474765 [6149-52-6]

cis-Ethyl 2-hydroxycyclohexanecarboxylate

Similarity: 0.85